104 Results (Page 1 of 9)
US Markets Research Reports
US Diabetes Therapeutics Market Analysis
The US diabetes therapeutics market is projected to grow from $60.4 Bn in 2022 to $109.4 Bn by 2030, registering a CAGR of 7.7% during the forecast period of 2022-2030. Diabetes is a chronic disease that affects millions of people in the US. According to the Centers for Disease Control and Prevention (CDC), over 34 Mn people in the US have diabetes, and the prevalence of the disease is increasing. This has led to an increase in demand for diabetes therapeutics. Some of the key players in the US diabetes therapeutics market include Novo Nordisk, Sanofi, Eli Lilly and Company, AstraZeneca, and Merck & Co. These companies are focusing on research and development activities to introduce new and innovative drugs and therapies to address the unmet needs of diabetic patients.
US Depression Therapeutics Market Analysis
The US depression therapeutics market is projected to grow from $4.2 Bn in 2022 to $5.5 Bn by 2030, registering a CAGR of 3.2% during the forecast period of 2022-30. The key players in the market include major pharmaceutical companies such as Pfizer, Inc., Eli Lilly and Company, and Johnson & Johnson, as well as smaller companies, focused on developing innovative new treatments and therapies for depression. Factors driving the growth of the US Depression Therapeutics Market include the increasing prevalence of depression, the growing acceptance of mental health issues, and the development of new and innovative treatments and therapies.
US Cardiovascular Diseases Therapeutics Market Analysis
The US Cardiovascular Disease (CVD) therapeutics market is projected to grow from $68.3 Bn in 2022 to $102.6 Bn by 2030, registering a CAGR of 5.22% during the forecast period of 2022-30. CVD is the leading cause of death in the US and affects a significant portion of the population. This high prevalence of CVD creates a large market for CVD treatments and drives demand for new and innovative therapies. Some of the key players in the US CVD therapeutics market include Pfizer, Novartis, Merck & Co., Sanofi, Bristol-Myers Squibb, and Amgen.
US Cancer Immunotherapy Market Analysis
The US cancer immunotherapy market is projected to grow from $47.3 Bn in 2022 to $70.4 Bn by 2030, registering a CAGR of 5.1% during the forecast period of 2022 - 2030. Cancer is a leading cause of death worldwide, and its prevalence is increasing due to factors such as an aging population and changing lifestyles. This has led to a growing demand for effective cancer treatments, including immunotherapies. Key players in the market include Bristol-Myers Squibb, Merck & Co., Inc., Novartis International AG, Roche Holding AG, AstraZeneca plc, Amgen Inc., and others.
US Anti Aging Therapeutics Market Analysis
The US anti-aging therapeutics market is projected to grow from $0.3 Bn in 2022 to $0.8 Bn by 2030, registering a CAGR of 14.53% during the forecast period of 2022-30. The market is a rapidly growing sector that includes a variety of products and services aimed at reducing or reversing the effects of aging. The key players in the market include Allergan, Inc., Lumenis Ltd., Cynosure, Inc., Personal Microderm, Johnson & Johnson, and Alma Lasers, among others. These companies are investing heavily in research and development to develop new and innovative products to meet the growing demand for anti-aging products and services.
US Advanced Therapy Medicinal Products (ATMPs) Market Analysis
The US Advanced Therapy Medicinal Products (ATMPs) market is projected to grow from $4.3 Bn in 2022 to $9.8 Bn by 2030, registering a CAGR of 11% during the forecast period of 2022-30. One of the key drivers of growth in the US ATMPs market is the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. These diseases often require long-term treatment, and ATMPs offer a promising new approach to treating them. Additionally, advances in gene editing technologies such as CRISPR/Cas9 have increased the potential for ATMPs to cure genetic disorders. Some of the major players are Novartis International AG, Gilead Sciences, Inc., Bluebird Bio, Inc., Spark Therapeutics, Inc., and Kite Pharma, Inc.
US ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
The US ADHD (Attention Deficit Hyperactivity Disorder) therapeutic market is projected to grow from $12.4 Bn in 2022 to $19.1 Bn by 2030, registering a CAGR of 5.5% during the forecast period of 2022-30. ADHD is one of the most common neurodevelopmental disorders in children, with an estimated prevalence of 6-9% in the US. The rising prevalence of ADHD is driving the demand for effective treatments and contributing to the growth of the market. Some key players in the US ADHD therapeutic market include Shire (now part of Takeda Pharmaceutical Company), Pfizer Inc., Novartis International AG, Johnson & Johnson, Eli Lilly and Company, and GlaxoSmithKline plc.
US Coronary Stents Market Analysis
The US coronary stents market is projected to grow from $4.7 Bn in 2022 to $5.9 Bn by 2030, registering a CAGR of 2.75% during the forecast period of 2022-30. The US coronary stents market is driven by several factors, including the high prevalence of coronary artery disease (CAD) in the US, advances in stent technology, and increasing demand for minimally invasive procedures. The market is highly competitive, with several major players such as Abbott Laboratories, Boston Scientific Corporation, and Medtronic dominating the market. These companies invest heavily in research and development to develop innovative stent technologies that provide better outcomes for patients.
US Contraceptive Devices Market Analysis
The US contraceptive devices market is projected to grow from $5.4 Bn in 2022 to $8.6 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The US contraceptive devices market is a growing and dynamic market that includes a range of products designed to prevent pregnancy. Bayer is a German multinational pharmaceutical company that manufactures a range of contraceptive products, including oral contraceptives and IUDs.
US Biomaterials in Healthcare Market Analysis
The US biomaterials in the healthcare market are projected to grow from $65.6 Bn in 2022 to $153.4 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-30. Chronic diseases such as cardiovascular disease, cancer, and diabetes are on the rise in the US. The market is highly competitive, with several key players, including BASF SE, DSM NV, Invibio Ltd., Carpenter Technology Corporation, Evonik Industries AG, and Royal DSM. These companies invest heavily in research and development to develop new biomaterials and improve the performance of existing ones.
US 3D Printing Medical Devices Market Analysis
The US 3D printing medical devices market is projected to grow from $1.2 Bn in 2022 to $3.6 Bn by 2030, registering a CAGR of 14.3% during the forecast period of 2022-30. 3D printing enables medical devices to be customized to the individual patient's needs, which can improve patient outcomes and satisfaction. The US 3D printing medical devices market is highly competitive, with several established players and new entrants vying for market share. Some of the major players in the US 3D printing medical devices market include Stratasys, Stryker Corporation, 3D Systems, and Materialise NV
US Cardiac Monitoring Devices Market Analysis
The US cardiac monitoring device market is projected to grow from $12.1 Bn in 2022 to $15 Bn by 2030, registering a CAGR of 2.7% during the forecast period of 2022-30. The US cardiac monitoring device market is expected to continue growing as the demand for accurate and reliable Cardiac Monitoring devices increases. Medtronic is a leading medical device company that offers a range of cardiac monitoring devices, including implantable cardiac monitors, pacemakers, and defibrillators.
US ENT Devices Market Analysis
The US ENT devices market is projected to grow from $9.7 Bn in 2022 to $13.1 Bn by 2030, registering a CAGR of 3.75% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. According to the National Institute on Deafness and Other Communication Disorders, approximately 15% of American adults (37.5 million) aged 18 and over report some trouble hearing. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. Some of the key players in the market include Cochlear Limited, William Demant Holding A/S, Medtronic plc, Stryker Corporation, and Olympus Corporation.
US Radiotherapy Market Analysis
The US radiotherapy market is projected to grow from $2.9 Bn in 2022 to $3.97 Bn by 2030, registering a CAGR of 4% during the forecast period of 2022-30. The market is primarily driven by factors such as increasing cancer prevalence, rising demand for non-invasive cancer treatments, and technological advancements in radiotherapy equipment. The US is one of the largest markets for radiotherapy globally, with a significant number of cancer treatment centers and a high level of investment in research and development. The key players in the US radiotherapy market include major medical device manufacturers and radiation therapy providers such as Varian Medical Systems, Elekta AB, Accuray Incorporated, and Siemens Healthineers.
US Liver Diseases Therapeutics Market Analysis
The US liver disease therapeutics market is projected to grow from $9.7 Bn in 2022 to $13 Bn by 2030, registering a CAGR of 3.7% during the forecast period of 2022-30. Liver diseases such as hepatitis, liver cancer, and NAFLD are becoming increasingly prevalent in the US population, driving demand for effective treatments. Some of the key players operating in the US liver disease therapeutics market include Gilead Sciences, Inc., AbbVie Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bristol-Myers Squibb, and Novartis AG. These companies are investing heavily in research and development to develop new and innovative treatments for liver disease and are expected to continue to drive the growth of the market in the coming years.
US Liver Cancer Therapeutics Market Analysis
The US liver cancer therapeutics market is projected to grow from $1.2 Bn in 2022 to $3.9 Bn by 2030, registering a CAGR of 15.6% during the forecast period of 2022-30. The market for liver cancer therapeutics in the US is driven by factors such as the increasing prevalence of liver cancer, the growing demand for effective treatment options, and advancements in technology and drug development. In addition, the increasing use of combination therapies, the development of targeted therapies, and the focus on personalized medicine are also contributing to the growth of this market. The major players operating in the US liver cancer therapeutics market include pharmaceutical companies such as Bristol-Myers Squibb, Bayer Healthcare, Pfizer Inc., Eisai Co., Ltd., and F. Hoffmann-La Roche AG.
US Infectious Disease Therapeutics Market Analysis
The US infectious disease therapeutics market is projected to grow from $50.3 Bn in 2022 to $60.6 Bn by 2030, registering a CAGR of 2.35% during the forecast period of 2022-30. Antibiotics are one of the most commonly prescribed classes of drugs for infectious diseases, but the rise of antibiotic-resistant bacteria has led to the development of new antibiotics and alternative therapies, such as antivirals and antifungals. Gilead Sciences is a biopharmaceutical company that develops and markets therapeutics for infectious diseases, including HIV/AIDS, hepatitis B and C, and influenza.
US In Vitro Fertilisation (IVF) Service Market Analysis
The US In Vitro Fertilization (IVF) services market is projected to grow from $7.5 Bn in 2022 to $13.2 Bn by 2030, registering a CAGR of 7.3% during the forecast period of 2022-30. The market is expected to be driven by factors such as rising infertility rates, increasing awareness and acceptance of ART procedures, and the availability of advanced reproductive technologies. The major players in the US IVF Services market include companies such as Vitrolife AB, CooperSurgical Inc., Ferring Pharmaceuticals Inc., Irvine Scientific, Merck KGaA, and OvaScience Inc. These companies offer a range of IVF products and services, including fertility drugs, laboratory equipment, and diagnostic tests.
US Healthcare Reimbursement Market Analysis
The US healthcare reimbursement market is projected to grow from $2306 Bn in 2022 to $6440 Bn by 2030, registering a CAGR of 13.70% during the forecast period of 2022-30. Changes in healthcare policies and regulations, such as the Affordable Care Act (ACA) and the Medicare Access and CHIP Reauthorization Act (MACRA), are driving the adoption of new reimbursement models and payment strategies. Major health insurance companies in the US include UnitedHealth Group, Anthem, Aetna, Cigna, and Humana.
US Healthcare Claims Management Market Analysis
The US healthcare claims management market is projected to grow from $11 Bn in 2022 to $53 Bn by 2030, registering a CAGR of 21.4% during the forecast period of 2022-30. Healthcare organizations are increasingly focused on improving patient outcomes and delivering high-quality care. This includes ensuring that claims are processed accurately and quickly so that patients can receive the care they need in a timely manner. There are several key players in the market, including Cerner Corporation, Allscripts Healthcare Solutions, Inc., and McKesson Corporation. These companies offer a range of solutions, including software and services, to help healthcare providers manage their claims and billing processes efficiently.
US Connected Healthcare Market Analysis
The US connected healthcare market is projected to grow from $28 Bn in 2022 to $182 Bn by 2030, registering a CAGR of 26.4% during the forecast period of 2022-30. The US Connected Healthcare market is highly competitive, with a wide range of companies offering products and services in this space. Major players include Apple, Google, Philips, and Samsung, as well as numerous startups and smaller companies. The widespread use of smartphones, tablets, and other mobile devices has led to the growth of mHealth technologies such as mobile health apps, wearables, and telehealth services, which enable patients to receive healthcare services remotely.
US Neurology Clinical Trials Market Analysis
The US neurology clinical trials market is projected to grow from $2.20 Bn in 2022 to $2.89 Bn by 2030, registering a CAGR of 3.5% during the forecast period of 2022 - 2030. The prevalence of neurological disorders in the US is on the rise, with an aging population and changing lifestyles being significant contributors. As a result, there is a growing need for effective treatments and therapies to manage and treat these conditions, leading to an increase in neurology clinical trials. The US neurology clinical trials market is expected to grow significantly in the coming years, driven by an increasing prevalence of neurological disorders, a growing aging population, and advancements in technology and treatments.
US ECG Equipments Market Analysis
The US ECG equipment market is projected to grow from $3.7 Bn in 2022 to $5.7 Bn by 2030, registering a CAGR of 5.3% during the forecast period of 2022-2030. Cardiovascular Diseases (CVDs) are the leading cause of death in the United States, and ECG equipment is an essential tool for diagnosing these conditions. The rising prevalence of CVDs is driving the demand for ECG equipment. Some of the key players in the US ECG equipment market include GE Healthcare, Philips Healthcare, Nihon Kohden Corporation, Hill-Rom Holdings, Inc., and Schiller AG.
US eHealth Market Analysis
The US eHealth Market is projected to grow from $70 Bn in 2022 to $223 Bn by 2030, registering a CAGR of 15.6% during the forecast period of 2022 - 2030. The US eHealth market is driven by factors such as increasing healthcare costs, an aging population, the prevalence of chronic diseases, and the need to improve healthcare outcomes. Digital technologies and services are seen as a way to address these challenges by improving patient engagement, increasing access to care, and reducing healthcare costs. Amazon Pharmacy is a recent entrant to the e-pharmacy market, offering prescription medications and other healthcare products through its online marketplace.
US ePharmacy Market Analysis
The US ePharmacy Market is projected to grow from $21 Bn in 2022 to $86 Bn by 2030, registering a CAGR of 19.3% during the forecast period of 2022 - 2030. The US ePharmacy market is driven by a number of factors, including the increasing demand for convenient and cost-effective healthcare solutions, the rise in chronic diseases and the aging population, and the growing adoption of technology in the healthcare industry. CVS Health is one of the largest ePharmacy players in the United States, with a market share of around 25%. The company offers a range of services, including prescription fulfillment, mail-order delivery, and specialty pharmacy services.